Back to Newsroom
Back to Newsroom

CBD Life Sciences Inc. (CBDL) Updates Its Shareholders for 2021

Tuesday, 29 December 2020 07:00 AM

CBD Life Sciences Inc.

SCOTTSDALE, AZ / ACCESSWIRE / December 29, 2020 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson is updating the shareholders for 2021!

The Company is proud to say that the CBD straws & Flower are in production through the Greenhouse facility. This Facility is also providing CBD Life Sciences with Full Spectrum Oil & Premium CBD Isolate. This speaks volumes for the company, and it will bring outstanding revenue to the table. The straws will be going into Big Chain Restaurants and Convenience Stores in Arizona. President & CEO Lisa Nelson stated, "We are so thankful for the Arizona Prop 207 that passed recently, because it puts us in a great spot for recreation, expansion and enhancement of the Farm Business moving forward for the New Year; the Harvest season starts in April 2021 and the company is going to expand miraculously and we are going to blow all competition out of the water with what we have planned in the upcoming months!"

CBD Life Sciences Inc., Tuesday, December 29, 2020, Press release picture

CBD Life Sciences Inc., Tuesday, December 29, 2020, Press release picture

Link to video: https://streamable.com/znupwq

The number of benefits CBD has is tremendous! These benefits include help with behavioral/neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.

LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices with its Holiday Specials. Check out LBC Bioscience Inc's newest product offerings including its: 100mg CBD Bath Bombs. 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

Why Shop LBC Bioscience?

  • Free Shipping on All Orders for the Holidays

  • Large Selection of Products (over 50 items and growing)

  • 100% USA Made Products "organic & kosher"

  • 50% off on all products through the Holidays using code "LBC50"

LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.

Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:

LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience

About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.

Contact:
Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480)326-8577
Email: [email protected]
Website: www.tenassociatesllc.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking

SOURCE: CBD Life Sciences Inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: